The effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN study

Journal of Lipid Research

Volumn 49, Issue 8, 2008, Pages 1839-1845

  Shen, Jian ^a   Arnett, Donna K ^b   Pérez Martínez, Pablo ^a,c   Parnell, Laurence D ^a   Lai, Chao Qiang ^a   Peacock, James M ^d   Hixson, James E ^e   Tsai, Michael Y ^d   Straka, Robert J ^f   Hopkins, Paul N ^g   Ordovás, José M ^a  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g UNIVERSITY OF UTAH   (United States)

Author keywords

Cardiovascular disease; Fat load; Inflammation; Postprandial response; Triglyceride rich lipoproteins

Indexed keywords

CARBOHYDRATE; CYTOSINE; FAT; GUANINE; INTERLEUKIN 6; PROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CALORIE; CARDIOVASCULAR RISK; CAUCASIAN; CONTROLLED STUDY; CYTOKINE RELEASE; DYSLIPIDEMIA; FAT INTAKE; FEMALE; GENE LOCUS; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERLIPIDEMIA; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; PARTICLE SIZE; POSTPRANDIAL STATE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN-6; LIPID METABOLISM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 49449118480     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P700033-JLR200     Document Type: Article

References (49)

1. Libby, P. 2002. Inflammation in atherosclerosis. Nature. 420: 868-874.
2. Ridker, P. M., N. J. Brown, D. E. Vaughan, D. G. Harrison, and J. L. Mehta. 2004. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation. 109: IV6-IV19.
3. Khovidhunkit, W., M. S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld. 2004. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J. Lipid Res. 45: 1169-1196.
4. Stein, J. H., M. A. Merwood, J. B. Bellehumeur, P. E. McBride, D. A. Wiebe, and J. M. Sosman. 2005. Postprandial lipoprotein changes in patients taking antiretroviral therapy for HIV infection. Arterioscler.Thromb. Vasc. Biol. 25: 399-405.
5. Georgiadis, A. N., E. C. Papavasiliou, E. S. Lourida, Y. Alamanos, C. Kostara, A. D. Tselepis, and A. A. Drosos. 2006. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment-a prospective, controlled study. Arthritis Res. Ther. 8: R82.
6. Howard, B. V., G. Ruotolo, and D. C. Robbins. 2003. Obesity and dyslipidemia. Endocrinol. Metab. Clin. North Am. 32: 855-867.
7. Haffner, S. M. 2002. Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance. Am. J. Cardiol. 90: 55i-61i.
8. Wyszynski, D. F., D. M. Waterworth, P. J. Barter, J. Cohen, Y. A. Kesaniemi, R. W. Mahley, R. McPherson, G. Waeber, T. P. Bersot, S. S. Sharma, et al. 2005. Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am. J. Cardiol. 95: 194-198.
9. Schaefer, E. J., J. R. McNamara, P. K. Shah, K. Nakajima, L. A. Cupples, J. M. Ordovas, and P. W. Wilson. 2002. Elevated remnantlike particle cholesterol and triglyceride levels in diabetic men and women in the Framingham Offspring Study. Diabetes Care. 25: 989-994.
10. Lewis, G. F., N. M. O'Meara, P. A. Soltys, J. D. Blackman, P. H. Iverius, A. F. Druetzler, G. S. Getz, and K. S. Polonsky. 1990. Postprandial lipoprotein metabolism in normal and obese subjects: comparison after the vitamin A fat-loading test. J. Clin. Endocrinol. Metab. 71: 1041-1050.
11. Sekhar, R. V., F. Jahoor, H. J. Pownall, K. Rehman, J. Gaubatz, D. Iyer, and A. Balasubramanyam. 2005. Severely dysregulated disposal of postprandial triacylglycerols exacerbates hypertriacylglycerolemia in HIV lipodystrophy syndrome. Am. J. Clin. Nutr. 81: 1405-1410.
12. Karpe, F. 1999. Postprandial lipoprotein metabolism and atherosclerosis. J. Intern. Med. 246: 341-355.
13. Roche, H. M., and M. J. Gibney. 2000. The impact of postprandial lipemia in accelerating atherothrombosis. J. Cardiovasc. Risk. 7: 317-324.
14. Lopez-Miranda, J., P. Perez-Martinez, C. Marin, J. A. Moreno, P. Gomez, and F. Perez-Jimenez. 2006. Postprandial lipoprotein metabolism, genes and risk of cardiovascular disease. Curr. Opin. Lipidol. 17: 132-138.
15. Papanicolaou, D. A., and A. N. Vgontzas. 2000. Interleukin-6: the endocrine cytokine. J. Clin. Endocrinol. Metab. 85: 1331-1333.
16. Fried, S. K., D. A. Bunkin, and A. S. Greenberg. 1998. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 83: 847-850.
17. Wannamethee, S. G., P. H. Whincup, A. Rumley, and G. D. Lowe. 2007. Inter-relationships of interleukin-6, cardiovascular risk factors and the metabolic syndrome among older men. J. Thromb. Haemost. 5: 1637-1643.
18. Glund, S., A. Deshmukh, Y. C. Long, T. Moller, H. A. Koistinen, K. Caidahl, J. R. Zierath, and A. Krook. 2007. Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle. Diabetes. 56: 1630-1637.
19. Mohamed-Ali, V., S. Goodrick, A. Rawesh, D. R. Katz, J. M. Miles, J. S. Yudkin, S. Klein, and S. W. Coppack. 1997. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factoralpha, in vivo. J. Clin. Endocrinol. Metab. 82: 4196-4200.
20. Stouthard, J. M., J. A. Romijn, T. Van der Poll, E. Endert, S. Klein, P. J. Bakker, C. H. Veenhof, and H. P. Sauerwein. 1995. Endocrinologic and metabolic effects of interleukin-6 in humans. Am. J. Physiol. 268: E813-E819.
21. Bastard, J. P., C. Jardel, E. Bruckert, P. Blondy, J. Capeau, M. Laville, H. Vidal, and B. Hainque. 2000. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J. Clin. Endocrinol. Metab. 85: 3338-3342.
22. Memon, R. A., W. M. Holleran, A. H. Moser, T. Seki, Y. Uchida, J. Fuller, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold. 1998. Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin. Arterioscler. Thromb. Vasc. Biol. 18: 1257-1265.
23. de Craen, A. J., D. Posthuma, E. J. Remarque, A. H. van den Biggelaar, R. G. Westendorp, and D. I. Boomsma. 2005. Heritability estimates of innate immunity: an extended twin study. Genes Immun. 6: 167-170.
24. Fishman, D., G. Faulds, R. Jeffery, V. Mohamed-Ali, J. S. Yudkin, S. Humphries, and P. Woo. 1998. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 102: 1369-1376.
25. Higgins, M., M. Province, G. Heiss, J. Eckfeldt, R. C. Ellison, A. R. Folsom, D. C. Rao, J. M. Sprafka, and R. Williams. 1996. NHLBI Family Heart Study: objectives and design. Am. J. Epidemiol. 143: 1219-1228.
26. Corella, D., D. K. Arnett, M. Y. Tsai, E. K. Kabagambe, J. M. Peacock, J. E. Hixson, R. J. Straka, M. Province, C. Q. Lai, L. D. Parnell, et al. 2007. The -256T>C polymorphism in the apolipoprotein A-II gene promoter is associated with body mass index and food intake in the genetics of lipid lowering drugs and diet network study. Clin. Chem. 53: 1144-1152.
27. Shen, J., D. K. Arnett, J. M. Peacock, L. D. Parnell, A. Kraja, J. E. Hixson, M. Y. Tsai, C. Q. Lai, E. K. Kabagambe, R. J. Straka, et al. 2007. Interleukin1beta genetic polymorphisms interact with poly-unsaturated fatty acids to modulate risk of the metabolic syndrome. J. Nutr. 137: 1846-1851.
28. Patsch, J. R., G. Miesenbock, T. Hopferwieser, V. Muhlberger, E. Knapp, J. K. Dunn, A. M. Gotto, Jr., and W. Patsch. 1992. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler. Thromb. 12: 1336-1345.
29. Otvos, J. D. 2002. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. Clin. Lab. 48: 171-180.
30. Singer, J. 1998. Using SAS PROC MIXED to Fit Multilevel Models, Hierarchical Models, and Individual Growth Models. J. Educ. Behav. Stat. 24: 323-355.
31. Proctor, S. D., and J. C. Mamo. 1998. Retention of fluorescentlabelled chylomicron remnants within the intima of the arterial wall-evidence that plaque cholesterol may be derived from postprandial lipoproteins. Eur. J. Clin. Invest. 28: 497-503.
32. Brunzell, J. D., W. R. Hazzard, D. Porte, Jr., and E. L. Bierman. 1973. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J. Clin. Invest. 52: 1578-1585.
33. Potts, J. L., R. M. Fisher, S. M. Humphreys, S. W. Coppack, G. F. Gibbons, and K. N. Frayn. 1991. Peripheral triacylglycerol extraction in the fasting and post-prandial states. Clin. Sci. (Lond.). 81: 621-626.
34. Jones, K. G., D. J. Brull, L. C. Brown, M. Sian, R. M. Greenhalgh, S. E. Humphries, and J. T. Powell. 2001. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation. 103: 2260-2265.
35. Humphries, S. E., L. A. Luong, M. S. Ogg, E. Hawe, and G. J. Miller. 2001. The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur. Heart J. 22: 2243-2252.
36. Fernandez-Real, J. M., M. Broch, J. Vendrell, C. Richart, and W. Ricart. 2000. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J. Clin. Endocrinol. Metab. 85: 1334-1339.
37. Halverstadt, A., D. A. Phares, S. Roth, R. E. Ferrell, A. P. Goldberg, and J. M. Hagberg. 2005. Interleukin-6 genotype is associated with high-density lipoprotein cholesterol responses to exercise training. Biochim. Biophys. Acta. 1734: 143-151.
38. Terry, C. F., V. Loukaci, and F. R. Green. 2000. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J. Biol. Chem. 275: 18138-18144.
39. Fife, M. S., E. M. Ogilvie, D. Kelberman, J. Samuel, A. Gutierrez, S. E. Humphries, and P. Woo. 2005. Novel IL-6 haplotypes and disease association. Genes Immun. 6: 367-370.
40. Rivera-Chavez, F. A., D. L. Peters-Hybki, R. C. Barber, and G. E. O'Keefe. 2003. Interleukin-6 promoter haplotypes and interleukin-6 cytokine responses. Shock (Augusta, Ga. 20: 218-223.
41. Stephens, J. W., S. J. Hurel, J. A. Cooper, J. Acharya, G. J. Miller, and S. E. Humphries. 2004. A common functional variant in the interleukin-6 gene is associated with increased body mass index in subjects with type 2 diabetes mellitus. Mol. Genet. Metab. 82: 180-186.
42. Fernandez-Real, J. M., M. Broch, J. Vendrell, C. Gutierrez, R. Casamitjana, M. Pugeat, C. Richart, and W. Ricart. 2000. Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes. 49: 517-520.
43. Watt, M. J., A. L. Carey, E. Wolsk-Petersen, F. B. Kraemer, B. K. Pedersen, and M. A. Febbraio. 2005. Hormone-sensitive lipase is reduced in the adipose tissue of patients with type 2 diabetes mellitus: influence of IL-6 infusion. Diabetologia. 48: 105-112.
44. Nonogaki, K., G. M. Fuller, N. L. Fuentes, A. H. Moser, I. Staprans, C. Grunfeld, and K. R. Feingold. 1995. Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology. 136: 2143-2149.
45. Goldberg, I. J. 1996. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res. 37: 693-707.
46. Greenberg, A. S., R. P. Nordan, J. McIntosh, J. C. Calvo, R. O. Scow, and D. Jablons. 1992. Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. Cancer Res. 52: 4113-4116.
47. Semenkovich, C. F., M. Wims, L. Noe, J. Etienne, and L. Chan. 1989. Insulin regulation of lipoprotein lipase activity in 3T3-L1 adipocytes is mediated at posttranscriptional and posttranslational levels. J. Biol. Chem. 264: 9030-9038.
48. Eichenbaum-Voline, S., M. Olivier, E. L. Jones, R. P. Naoumova, B. Jones, B. Gau, H. N. Patel, M. Seed, D. J. Betteridge, D. J. Galton, et al. 2004. Linkage and association between distinct variants of the APOA1/ C3/A4/A5 gene cluster and familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 24: 167-174.
49. Rothman, K. J. 1990. No adjustments are needed for multiple comparisons. Epidemiology. 1: 43-46.